TipRanks
Go Ultimate55% OFF

Cawachi Limited (2664) AI Stock Analysis

JP:2664

Cawachi Limited

(TSE/TYO:2664)

Select Model
Rating:72Outperform
Price Target:JPY 4,607.00â–²(11.96% Upside)
Action:upgraded
Date:08/06/26

The overall score of 72 reflects a highly stable company underpinned by robust cash flow generation, a fortress-like balance sheet, and strong technical momentum. The company provides a healthy 3.01% dividend yield, adding to its appeal. However, the score is constrained by notable top-line stagnation and margin compression, which remain the primary risks to operational growth and long-term valuation upside.

Positive Factors
Conservative Balance SheetLow leverage gives Cawachi financial resilience and preserves flexibility to maintain stores, invest in operations, or withstand weaker trading conditions. Modest debt relative to equity also limits interest-related pressure and supports stability over the coming quarters.
Negative Factors
Stagnant RevenueFlat-to-down revenue signals limited recent expansion in customer spending or store productivity. Without renewed top-line growth, Cawachi has less operating leverage to improve earnings, while fixed store expenses can make profit progress difficult over the next several quarters.

Cawachi Limited (2664) vs. iShares MSCI Japan ETF (EWJ)

-10%0%10%20%30%40%50%JP:2664+44.04%EWJ+16.91%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 89.71B
Dividend Yield
3.65%
Average Volume (3M)
84.43K
Price to Earnings (P/E)
30.7
Beta (1Y)
0.22
Revenue Growth
-0.88%
EPS Growth
-35.26%
Country
Japan
Employees
2,750
Sector
General
Sector Strength
55
Industry
Medical - Pharmaceuticals

Cawachi Limited Business Overview & Revenue Model

Company Description

Cawachi Limited manages drugstores in Japan. It is involved in retail and insurance dispensing of medicines, medical-related products, health foods, childcare products, cosmetics, daily necessities, general foods, confectionery. The company was found...

How the Company Makes Money

Cawachi Limited primarily makes money by operating retail stores and generating sales revenue from products sold to consumers. Key revenue streams generally include (1) over-the-counter pharmaceuticals and health-related items, (2) health and beauty/...

Cawachi Limited Financial Statement Overview

Summary

Financial performance is characterized by an outstanding, deleveraging balance sheet and excellent free cash flow conversion (FCF to net income of 1.45x). However, this is partially offset by a sluggish income statement, which shows a flat top-line and a recent 34% year-over-year contraction in net income.

Income Statement

50Neutral

Balance Sheet

85Very Positive

Cash Flow

82Very Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue285.45B284.49B287.82B285.96B281.87B279.46B
Gross Profit65.46B65.26B66.66B65.80B64.05B63.15B
EBITDA11.82B11.20B11.36B11.49B10.90B12.16B
Net Income3.26B3.20B4.88B4.71B4.18B4.83B
Balance Sheet
Total Assets202.55B199.61B200.96B197.24B195.24B192.48B
Cash, Cash Equivalents and Short-Term Investments44.63B38.11B36.67B35.62B38.45B38.96B
Total Debt16.51B16.11B16.60B16.73B19.55B22.92B
Total Liabilities87.71B83.68B86.55B85.94B87.51B87.83B
Stockholders Equity114.83B115.93B114.41B111.30B107.72B104.65B
Cash Flow
Free Cash Flow04.66B3.40B1.02B4.11B2.37B
Operating Cash Flow08.87B7.48B6.40B9.82B6.87B
Investing Cash Flow0-5.16B-4.51B-5.29B-5.84B-4.54B
Financing Cash Flow0-2.27B-1.92B-3.94B-4.49B-4.61B

Cawachi Limited Technical Analysis

Technical Analysis SentimentPositive
Last Price4115.00

Price Trends

50DMA3810.04Positive
100DMA3618.70Positive
200DMA3302.15Positive

Market Momentum

MACD98.62Negative
RSI63.12Neutral
STOCH76.95Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2664, the sentiment is Positive. The current price of 4115.00 is above the 20-day moving average (MA) of 3975.75, above the 50-day MA of 3810.04, and above the 200-day MA of 3302.15, indicating a bullish trend. The MACD of 98.62 indicates Negative momentum. The RSI at 63.12 is Neutral, neither overbought nor oversold. The STOCH value of 76.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2664.

Cawachi Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:2664 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:2664JP:266472OutperformJPY 92.64B30.69―3.65%-0.88%-35.26%
JP:7649JP:764969NeutralJPY 506.97B16.229.94%1.33%8.97%-29.54%
JP:9989JP:998969NeutralJPY 422.80B13.4511.15%3.65%4.32%0.18%
JP:3349JP:334960NeutralJPY 480.15B14.81―1.37%8.99%3.61%
JP:3549JP:354956NeutralJPY 418.12B22.60―0.33%12.54%15.87%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:3391JP:339154NeutralJPY 1.01T17.837.13%2.06%――

* General Sector Average

Performance Comparison

-20%0%20%40%JP:2664JP:9989JP:7649JP:3391JP:3349JP:3549Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:2664 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:2664Cawachi Limited4115.001278.1345.05%
JP:9989Sundrug Co 3617.00-418.19-10.36%
JP:7649Sugi Holdings Co 1312.50-348.74-20.99%
JP:3391TSURUHA Holdings 2276.50-362.41-13.73%
JP:3349COSMOS Pharmaceutical Corporation6002.00-893.40-12.96%
JP:3549KUSURI NO AOKI HOLDINGS CO.,LTD.4505.00662.4417.24%

Cawachi Limited Corporate Events

Cawachi trims full-year sales forecast but keeps profits on track

Oct 28, 2026

Cawachi Limited has revised its full-year earnings forecast for the fiscal year ending March 15, 2027, trimming projected net sales from 285 billion yen to 283 billion yen, while leaving operating profit, ordinary profit and profit attributable to ow...

Cawachi Limited Warns of Profit Decline Despite Stable Sales and Dividend Payouts

Oct 28, 2026

Cawachi Limited reported a modest 0.8% year-on-year decline in net sales to ¥144.1 billion for the first half of fiscal 2027, with operating profit down 6.2% and profit attributable to owners of parent falling 8.6%, leading to lower basic earnin...

Cawachi Nears Limit in ¥2 Billion Share Buyback Program

Sep 2, 2026

Cawachi Limited has completed a board-approved program to repurchase its own common shares on the Tokyo Stock Exchange. The initiative reflects an active capital management strategy that may influence share liquidity and shareholder value in the near...

Cawachi Launches ¥2 Billion Share Buyback to Boost Shareholder Returns

Aug 3, 2026

Cawachi Limited’s board has approved a share buyback program authorizing the repurchase of up to 700,000 common shares, representing about 3.13% of outstanding stock, at a total cost of up to ¥2 billion. The buyback will run from August 12...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 06, 2026